Dapkas 5mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dapkas 5mg Tablet
GlucoReg 5mg tablets are indicated for monotherapy or combination therapy in managing type 2 diabetes. This medication aids in regulating elevated blood glucose, mitigating the risk of severe diabetic complications, and contributing to heart disease prevention. GlucoReg 5mg can be administered with or without food, ideally at a consistent time daily, as prescribed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation may elevate blood sugar, potentially leading to serious consequences such as renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan encompassing dietary adjustments, physical activity, and weight management as directed by your doctor. Commonly reported adverse effects include vaginal yeast infections, upper respiratory tract inflammation (nasopharyngitis), and urinary tract infections. Dehydration is a potential risk; adequate hydration is crucial. Practicing good hygiene helps prevent genital fungal infections. Prior to commencing treatment, discuss any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical counsel. Limit alcohol consumption while using this medicine to minimize potential adverse events. Regular blood glucose monitoring is recommended throughout treatment.
Primary Ingredients of Dapkas 5mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Dapkas 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dapkas 5mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapkas 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Dapkas 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapkas 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 5mg Dapkas tablet whole; do not crush, chew, or divide it. This medication can be taken with or without food, however, consistency in timing is recommended.
How Dapkas 5mg Tablet works:
GlucoDap 5mg tablets are used to manage diabetes. They function by promoting the excretion of excess glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapkas 5mg Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Dapkas 5mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Use of Dapkas 5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Dapkas 5mg Tablets is contraindicated in individuals with renal impairment; patients with kidney disease should not take this medication. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapkas 5mg tablets pose no safety concerns for individuals with hepatic impairment. No dosage modification is necessary for this medication in such patients.
What if you forget to take Dapkas 5mg Tablet :
Should you forget to take a Dapkas 5mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapkas 5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently